Back to Rankings

NVCT

NuvectisD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NVCT vs peer average
27/100
NVCT vs. peer average (D vs. C)
Grade spread
A 4 · B 2 · C 2 · D 1 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CABA is the first available peer comparator.

Clinical-stage small-cap biotech peer with similar financing and catalyst-driven volatility, though therapeutic focus is not oncology and therefore peer fit is only moderate.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCABACabaletta Bio
NVCT
Nuvectis
CABA
Cabaletta Bio
Grade
D
D
Momentum
100
9
Value
41
41
Sentiment
0
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CABA

NVCT / CABA
Grade Position
Below peers
NVCT vs. peer average (D vs. C)
27/100
Momentum
100
NVCT
Value
41
NVCT
Sentiment
0
CABA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NVCT
1
CABA
CABA
D
40/100
Even
2
PRQR
PRQR
F
20/100
+1
3
OVID
OVID
B
80/100
-2
4
CTKB
Cytek Biosciences Inc Common
C
60/100
-1
5
TECX
Tectonic Therapeutic Inc Common
C
60/100
-1
CABA is the first peer returned for this comparison set.